ClinicalTrials.gg
CompletedNCT00932685Updated Jul 3, 2009

Does Distraction With a Hand Held Video Game Reduce Preoperative and Emergence Anxiety in Children?

An interventional study of Midazolam and Game Boy in Pediatric Emergence Agitation and Pain, sponsored by University of Medicine and Dentistry of New Jersey. Completed at 1 site in United States. Open to participants aged 4 Years to 12 Years. Per ClinicalTrials.gov, last updated 2009-07-03.

Sponsored by University of Medicine and Dentistry of New Jersey · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
119
Allocation
Randomized
Ages
4 Years to 12 Years
Sex
All
01

Study summary

Preoperative anxiety is characterized by subjective feelings of tension, apprehension, nervousness and worry. In children, preoperative anxiety is reported to result in postoperative negative psychological effects, including nightmares, eating problems and increased fear of doctors. Previous studies have assessed anxiety in children during the preoperative period and the effects of premedication and parental presence. Midazolzam has been shown to reduce preoperative anxiety in children but post operative recovery maybe delayed for children undergoing a short operative procedure. Distraction may be particularly helpful in children ages 6-12 as these children are curious about their environment. An association between preoperative anxiety and emergence agitation has been suggested. Emergence agitation in children is not well understood but is a frightening experience for child and parent. A previous study demonstrated the efficacy of hand held video games used as an interactive distraction to allay preoperative anxiety. The purpose of this study is to treat preop anxiety with premedication, or video game and to evaluate the impact of these interventions on the incidence and severity of emergence agitation.

02

Conditions studied

  • Pediatric Emergence Agitation and Pain

Browse trials for

Keywords

  • pediatric emergence agitation and pain
03

In context

Pain

2,450 studies on the registry are indexed under Pain; 945 are open to participants now.

This study's enrollment of 119 is above the median of 70 across 2,101 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

University of Medicine and Dentistry of New Jersey is the lead sponsor of 105 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ASA rating of I-II Mask induction of General Anesthesia

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery Children who have developmental disabilities or chronic illness Children who have had repetitive surgeries Children who have excessive anxiety attacks or who are currently on benzopaines
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
119 participants (actual)

Study arms

  • Active comparator
    2. Video Game

    Device: Game Boy

  • Active comparator
    1. Midazolam 0.5mg/kg

    Drug: Midazolam

Interventions

  • Midazolam 0.5mg/kg

  • DeviceGame Boy

    Children given video game as a distraction in preop holding and were permitted to continue playing the game in OR during induction

    Also known as: Nintendo-DS Game Boy

06

What researchers measure

Primary outcomes

  1. postoperative pain

    Time frame: on arrival in PACU, at 10 min, at 30 min and 10 minutes prior to discharge

Secondary outcomes

  1. emergence agitation

    Time frame: on arrival, at 5 minutes and every 10 min for one hour in PACU

07

Study locations

1 site
  • University Hospital
    Newark, New Jersey 07101, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00932685
Collaborators
Nintendo of North America
First posted
Jul 3, 2009
Start date
Dec 2005
Primary completion
Jun 2007
Completion
Jul 2007
Last update
Jul 3, 2009

Study contacts

Anuradha Patel, MD
principal investigator · Rutgers, The State University of New Jersey

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Midazolam

Start the discussion